{"id":13993,"date":"2026-03-23T08:43:52","date_gmt":"2026-03-23T07:43:52","guid":{"rendered":"https:\/\/leo-foundation.org\/en\/?p=13993"},"modified":"2026-03-23T08:43:53","modified_gmt":"2026-03-23T07:43:53","slug":"the-leo-foundation-appoints-new-board-members","status":"publish","type":"post","link":"https:\/\/leo-foundation.org\/en\/2026\/03\/23\/the-leo-foundation-appoints-new-board-members\/","title":{"rendered":"The LEO Foundation appoints new board members"},"content":{"rendered":"\n
Press release, 23 March 2026<\/em><\/em><\/p>\n\n\n\n New board members<\/strong><\/p>\n\n\n\n Lars Olsen, Chair of the LEO Foundation Board, says<\/strong>: \u201cTina Sejersg\u00e5rd Fan\u00f8 and Adam Steensberg are accomplished leaders with deep experience spanning research, innovation and commercial execution in life science. Together with the rest of the Board, their expertise will be highly valuable as the LEO Foundation continues to pursue its ambitions across ownership, philanthropy, and investments \u2013 with the purpose of paving the way for curing skin diseases.\u201d<\/p>\n\n\n\n He adds: \u201cI would also like to warmly welcome the new employee-elected members to the Board. They bring important perspectives from across LEO Pharma, which are essential for the Board\u2019s work and an integral part of the Foundation\u2019s governance.\u201d<\/p>\n\n\n\n Other board changes<\/strong><\/p>\n\n\n\n Cristina Lage steps down as part of the regular board succession, having served on the Board since 2016. Lars Green, a board member since 2020, has decided to step down to focus on his other board commitments.<\/p>\n\n\n\n The three new employee-elected board members are replacing Allan Carsten Dahl (board member since 2015), Franck Mar\u00e9no (board member since 2021) and Jannie Kogsb\u00f8ll (board member since 1998).<\/p>\n\n\n\n Lars Olsen says: \u201cOn behalf of the Board, I would like to thank Cristina Lage and Lars Green for their significant efforts and dedication. We have benefited greatly from their expertise, and both have played instrumental roles in shaping the LEO Foundation into what it is today. I would also like to extend my sincere thanks to the outgoing employee-elected members for their strong engagement and valuable contributions.\u201d<\/p>\n\n\n\nThe LEO Foundation has appointed Tina Sejersg\u00e5rd Fan\u00f8, Executive Vice President at Novonesis, and Adam Steensberg, CEO of Zealand Pharma, to its Board of Trustees at the Annual Meeting on 20 March 2026. Three employee-elected members have also joined the Board.<\/h3>\n\n\n\n
\n